52,399 Shares in Aspen Aerogels, Inc. (NYSE:ASPN) Bought by Raymond James & Associates

Raymond James & Associates bought a new position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 52,399 shares of the construction company's stock, valued at approximately $827,000. Raymond James & Associates owned approximately 0.07% of Aspen Aerogels as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ASPN. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Aspen Aerogels by 71.4% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company's stock worth $198,000 after purchasing an additional 9,601 shares in the last quarter. Levin Capital Strategies L.P. lifted its holdings in shares of Aspen Aerogels by 48.3% in the 3rd quarter. Levin Capital Strategies L.P. now owns 70,613 shares of the construction company's stock worth $607,000 after purchasing an additional 23,000 shares in the last quarter. Principal Financial Group Inc. bought a new position in Aspen Aerogels during the 3rd quarter valued at $449,000. Rice Hall James & Associates LLC lifted its stake in Aspen Aerogels by 385.0% during the 3rd quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company's stock valued at $5,359,000 after acquiring an additional 494,662 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. bought a new position in Aspen Aerogels during the 3rd quarter valued at $334,000. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. TheStreet upgraded Aspen Aerogels from a "d+" rating to a "c-" rating in a research note on Wednesday, March 6th. Roth Mkm assumed coverage on Aspen Aerogels in a research note on Wednesday, March 6th. They set a "buy" rating and a $22.00 price objective on the stock. Canaccord Genuity Group raised their price objective on Aspen Aerogels from $13.00 to $17.00 and gave the company a "buy" rating in a research note on Wednesday, December 27th. HC Wainwright reaffirmed a "buy" rating and set a $20.00 target price on shares of Aspen Aerogels in a research report on Wednesday, February 14th. Finally, Canaccord Genuity Group raised their target price on Aspen Aerogels from $13.00 to $17.00 and gave the company a "buy" rating in a research report on Wednesday, December 27th. One equities research analyst has rated the stock with a sell rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $19.00.

Aspen Aerogels Stock Performance

Shares of Aspen Aerogels stock traded up $1.45 during trading hours on Tuesday, hitting $16.63. 924,267 shares of the company's stock traded hands, compared to its average volume of 967,910. Aspen Aerogels, Inc. has a 12-month low of $5.32 and a 12-month high of $19.10. The stock has a market capitalization of $1.28 billion, a price-to-earnings ratio of -25.20 and a beta of 2.04. The company has a fifty day simple moving average of $16.57 and a 200-day simple moving average of $13.21. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.41 and a quick ratio of 2.91.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. The firm had revenue of $84.22 million during the quarter, compared to analyst estimates of $83.82 million. During the same period last year, the firm posted ($0.20) EPS. Equities research analysts anticipate that Aspen Aerogels, Inc. will post -0.24 EPS for the current fiscal year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.